Table of Contents: 2012 NOVEMBER–DECEMBER No. 389
Revised Entry Combinations Table — 2013. NLM Tech Bull. 2012 Nov-Dec;(389):e4b.
| Previous MeSH Heading/Subheading (Entry Combination) |
Replaced-by Heading for 2013 |
|---|---|
| 4-Aminobenzoic Acid/analogs & derivatives | para-Aminobenzoates |
| Acetic Acid/analogs & derivatives | Acetates |
| Acid Sensing Ion Channels/agonists | Sodium Channel Agonists |
| Acid Sensing Ion Channels/antagonists & inhibitors | Acid Sensing Ion Channel Blockers |
| Benzoic Acid/analogs & derivatives | Benzoates |
| Butyric Acid/analogs & derivatives | Butyrates |
| Caspase 1/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 2/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 3/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 6/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 7/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 8/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 9/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 10/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 12/antagonists & inhibitors | Caspase Inhibitors |
| Caspase 14/antagonists & inhibitors | Caspase Inhibitors |
| Caspases/antagonists & inhibitors | Caspase Inhibitors |
| Caspases, Effector/antagonists & inhibitors | Caspase Inhibitors |
| Caspases, Initiator/antagonists & inhibitors | Caspase Inhibitors |
| Collagenases/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Degenerin Sodium Channels/agonists | Sodium Channel Agonists |
| Degenerin Sodium Channels/antagonists & inhibitors | Sodium Channel Blockers |
| Dichloroacetic Acid/analogs & derivatives | Chloroacetates |
| Epithelial Sodium Channels/agonists | Epithelial Sodium Channel Agonists |
| Epithelial Sodium Channels/antagonists & inhibitors | Epithelial Sodium Channel Blockers |
| Glucuronic Acid/analogs & derivatives | Glucuronates |
| Hearing Impaired Persons/education | Education of Hearing Disabled |
| Iodoacetic Acid/analogs & derivatives | Iodoacetates |
| Matrix Metalloproteinase 1/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 2/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 3/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 7/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 8/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 9/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 10/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 11/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 12/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 13/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 14/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 15/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 16/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 17/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinase 20/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinases/antagonists & inhibitors | Matrix Metalloproteinase Inhibitors |
| Matrix Metalloproteinases, Membrane-Associated/ antagonists & inhibitors |
Matrix Metalloproteinase Inhibitors |
| Mesenchymal Stromal Cells/transplantation | Mesenchymal Stem Cell Transplantation |
| NAV1.1 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.1 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| NAV1.2 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.2 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| NAV1.3 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.3 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| NAV1.4 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.4 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| NAV1.5 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.5 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| NAV1.6 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.6 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| NAV1.7 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.7 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| NAV1.8 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.8 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| NAV1.9 Voltage-Gated Sodium Channel/agonists | Voltage-Gated Sodium Channel Agonists |
| NAV1.9 Voltage-Gated Sodium Channel/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
| Organofluorophosphonates/poisoning | Organophosphate Poisoning |
| Organophosphates/poisoning | Organophosphate Poisoning |
| Organophosphonates/poisoning | Organophosphate Poisoning |
| Organophosphorus Compounds/poisoning | Organophosphate Poisoning |
| Organothiophosphates/poisoning | Organophosphate Poisoning |
| Organothiophosphonates/poisoning | Organophosphate Poisoning |
| Oxalic Acid/analogs & derivatives | Oxalates |
| Oxaloacetic Acid/analogs & derivatives | Oxaloacetates |
| Plants/growth & development | Plant Development |
| Proteasome Endopeptidase Complex/antagonists & inhibitors | Proteasome Inhibitors |
| Receptors, Cannabinoid/agonists | Cannabinoid Receptor Agonists |
| Receptors, Cannabinoid/antagonists & inhibitors | Cannabinoid Receptor Antagonists |
| Receptors, Mineralocorticoid/antagonists & inhibitors | Mineralocorticoid Receptor Antagonists |
| Research/methods | Research Design |
| Salicylic Acid/analogs & derivatives | Salicylates |
| Skin/surgery | Dermatologic Surgical Procedures |
| Sodium Channels/agonists | Sodium Channel Agonists |
| Succinic Acid/analogs & derivatives | Succinates |
| Tissues/transplantation | Tissue Transplantation |
| Trichloroacetic Acid/analogs & derivatives | Chloroacetates |
| Trifluoroacetic Acid/analogs & derivatives | Fluoroacetates |
| Visually Impaired Persons/education | Education of Visually Disabled |
| Voltage-Gated Sodium Channel beta Subunits/agonists | Voltage-Gated Sodium Channel Agonists |
| Voltage-Gated Sodium Channel beta Subunits/ antagonists & inhibitors |
Voltage-Gated Sodium Channel Blockers |
| Voltage-Gated Sodium Channel beta-1 Subunit/agonists | Voltage-Gated Sodium Channel Agonists |
| Voltage-Gated Sodium Channel beta-1 Subunit/ antagonists & inhibitors |
Voltage-Gated Sodium Channel Blockers |
| Voltage-Gated Sodium Channel beta-2 Subunit/agonists | Voltage-Gated Sodium Channel Agonists |
| Voltage-Gated Sodium Channel beta-2 Subunit/ antagonists & inhibitors |
Voltage-Gated Sodium Channel Blockers |
| Voltage-Gated Sodium Channel beta-3 Subunit/agonists | Voltage-Gated Sodium Channel Agonists |
| Voltage-Gated Sodium Channel beta-3 Subunit/ antagonists & inhibitors |
Voltage-Gated Sodium Channel Blockers |
| Voltage-Gated Sodium Channel beta-4 Subunit/agonists | Voltage-Gated Sodium Channel Agonists |
| Voltage-Gated Sodium Channel beta-4 Subunit/ antagonists & inhibitors |
Voltage-Gated Sodium Channel Blockers |
| Voltage-Gated Sodium Channels/agonists | Voltage-Gated Sodium Channel Agonists |
| Voltage-Gated Sodium Channels/antagonists & inhibitors | Voltage-Gated Sodium Channel Blockers |
